TROTTER Matthew William Burnell;POURDEHNAD Michael;GANDHI Anita;CELGENE CORPORATION;RISUENO-PEREZ Alberto;HAGNER Patrick
发明人:
TROTTER Matthew William Burnell,RISUENO-PEREZ Alberto,POURDEHNAD Michael,GANDHI Anita,HAGNER Patrick
申请号：
IL25809418
公开号：
IL258094D0
申请日:
2018.03.13
申请国别(地区):
IL
年份:
2018
代理人:
摘要：
In one aspect, provided herein are methods for predicting the responsiveness of DLBCL patients to treatment with lenolidomide or Compound A； or a stereoisomer thereof； or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate thereof； or a polymorph thereof utilizing biomarkers or classfiers that correlate with responsiveness to one of these drugs. In another aspect, provided herein are methods for treating a DLBCL patient determined to be responsive to treatment with lenolidomide or Compound A； or a stereoisomer thereof； or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate thereof； or a polymorph thereof utilizing biomarkers or classifiers (or output thereof) that correlate with responsiveness to one of these drugs.
